Recombinant BCG approach for development of vaccines: Cloning and expression of immunodominant antigens of M. tuberculosis

FEMS Microbiology Letters

Volumn 190, Issue 2, 2000, Pages 309-316

  Dhar, Neeraj ^a   Rao, Vivek ^a   Tyagi, Anil K ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Antigen 85 complex; Gene expression; Mycobacterium; Recombinant bacille Calmette Guerin

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE;

ANTIGEN EXPRESSION; ARTICLE; MOLECULAR CLONING; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUBERCULOSIS;

ANTIGENS, BACTERIAL; CLONING, MOLECULAR; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; IMMUNODOMINANT EPITOPES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); TRANSFORMATION, BACTERIAL; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0034666548     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00353-0     Document Type: Article

References (23)

1. Kochi, A. (1994) TB, A Global Emergency. WHO Report. WHO, Geneva.
2. Dolin P.J., Raviglione M.C., Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull. WHO. 72:1994;213-220.
3. Rodrigues L.C., Diwan V.K., Wheeler J.G. Protective efficacy of BCG against tuberculous meningitis and miliary tuberculosis: Meta-analysis. Int. J. Epidemiol. 22:1993;1154-1158.
4. Fine P.E.M. BCG vaccination against tuberculosis and leprosy. Br. Med. Bull. 44:1998;691-704.
5. Horwitz M.A., Lee B.E., Dillon B.J., Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular protein of M. tuberculosis. Proc. Natl. Acad. Sci. USA. 92:1995;1530-1534.
6. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., De Witt C.M., Orme I.M., Baldwin S., D'Souza C., Drowart A., Lozes E., Vandenbussche P., Van Vooren J.P., Liu M.A., Ulmer J.B. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2:1996;893-898.
7. Lozes E., Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Vandenbussche P., Van Vooren J.P., Drowart A., Ulmer J., Liu M.A. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine. 15:1997;830-833.
8. Guleria I., Teitelbaum R., McAdam R.A., Kalpana G., Jacobs W.R. Jr., Bloom B.R. Auxotrophic vaccines for tuberculosis. Nature Med. 2:1996;334-338.
9. Murray P.J., Aldovini A., Young R.A. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines. Proc. Natl. Acad. Sci. USA. 93:1996;934-939.
10. 37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w. Vaccine. 9:1991;10-14.
11. DasGupta S.K., Jain S., Kaushal D., Tyagi A.K. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines. Biochem. Biophys. Res. Commun. 246:1998;797-804.
12. Closs O., Harboe M., Axelsen N.H., Busch-Christensen K., Magnusson M. The antigens of M. bovis BCG studied by crossed immunoelectrophoresis a reference system. Scand. J. Immunol. 12:1980;249-263.
13. Wiker H.G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:1992;648-661.
14. Bashyam M.D., Kaushal D., DasGupta S.K., Tyagi A.K. A study of the mycobacterial transcription apparatus: identification of novel features in promoter elements. J. Bacteriol. 178:1996;4847-4853.
15. DasGupta S.K., Bashyam M.D., Tyagi A.K. Cloning and assessment of mycobacterial promoters by using a plasmid shuttle vector. J. Bacteriol. 175:1993;5186-5192.
16. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Mehra V., Sweetser D., Young R.A. Efficient mapping of protein antigenic determinants. Proc. Natl. Acad. Sci. USA. 83:1986;7013-7017.
19. Abou-Zeid C., Ratliff T.L., Wiker H.G., Harboe M., Bennedsen J., Rook G.A.W. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect. Immun. 56:1988;3046-3051.
20. Wiker H.G., Nagai S., Harboe M., Ljungqvist L. A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand. J. Immunol. 36:1992;307-319.
21. Harth G., Lee B.-Y., Wang J., Clemens D.L., Horwitz M.A. Novel insights into the genetics, biochemistry and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect. Immun. 64:1996;3038-3047.
22. Bloom, B.R. and Fine, P.E.M. (1994) Tuberculosis: Pathogenesis, Protection and Control, pp. 531-557. ASM Press. Washington, DC.
23. Stover C.K., de la Cruz V.F., Fuerst T.R., Burlein J.E., Benson L.A., Bennett L.T., Bansal G.P., Young J.F., Lee M.H., Hatfull G.F., Snapper S.B., Barletta R.G., Jacobs W.R. Jr., Bloom B.R. New use of BCG for recombinant vaccines. Nature. 351:1991;456-460.